Speaker profile

M. Schlageter joined the German entity of the Roche Group as Head of Treasury in 1993. In 1998 he became European Head of Cash & Credit Management in Switzerland for the Vitamins Division where he built up a Shared Service Center in this area. After the divestment of the Vitamins Division in 2004 he joined Roche’s Group Treasury as Head of Treasury Operations where he implemented the InHouse bank. Before joining Roche he worked several years in foreign exchange trading in Frankfurt, Singapore and Paris. M. Schlageter holds a degree of the University of Applied Sciences, Rendsburg (Germany).

Corporate profile

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.